Association of myosin light chain kinase with lymphocyte membrane-cytoskeleton complex.

Rare Protein-altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis.

An exploration of ambigrammatic sequences in narnaviruses.

Sexual dimorphism in the nociceptive effects of hyaluronan.

ZSFG Medicine Grand Rounds - MGR 22028

Durga Roy, MD, FACLP

Assistant Professor, Medical Director, Johns Hopkins Bayview Neuropsychiatry Clinic, Director of Education, Bayview Psychiatry Director, Consult-Liaison Psychiatry Fellowship, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine

Learning Objectives: 

1. Identify rates of neuropsychiatric disturbances in the first year of TBI

2. Identify clinical and demographic risk factors associated with the development of neuropsychiatric disturbances within the first year of TBI

3. List the pharmacologic interventions used to treat neuropsychiatric disturbances after TBI

4. List the psychosocial interventions used to treat neuropsychiatric disturbances after TBI

Disclosure: Planners Elizabeth Harleman, MD; Melody Davenport-McLaughlin, BA, and Evelina Azarian, BA have stated they have no financial relationships to disclose. Speaker Durga Roy, MD, FACLP has no financial relationships to disclose.

Accreditation: The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  

Designation: UCSF designates this live activity for a maximum of 64 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The above credit is inclusive of all Fiscal year 2022 SFGH Medicine Grand rounds sessions.  You must sign in to Qualtrics to qualify for CME credit.

Zoom Information

http://tiny.ucsf.edu/DOMGrandRounds

Meeting ID: 968 1679 7792
Password: 1001
Call-in: +1 669 900 6833, +1 213 338 8477, +1 669 219 259

This presentation will be recorded and is accessible through My Access

https://lecture.ucsf.edu/ets/Catalog/Full/ab21c2921423425398199ec7e0720d6a2

Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.

IFNα-blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health.

Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2- advanced breast cancer.

Managed care reflections: a Q&A with Julia Adler-Milstein, PhD.

Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS.

Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes.

Basal and alpha1-adrenergic-induced activity of minimal rat betaMHC promoters in cardiac myocytes requires multiple TEF-1 but not NFAT binding sites.

Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VI.

Human-Centered Design Lessons for Implementation Science: Improving the Implementation of a Patient-Centered Care Intervention.

In Memoriam: Remembering Nephrologist Anitha Toke

Dear Colleagues,

 We write to share the sad news that Dr. Anitha Toke passed away on Friday, September 17th. Dr. Toke was an highly valued member of our DOM faculty, based in the Nephrology Division at ZSFG. She was an outstanding teacher, mentor, clinician, role model, and leader.  

 Dr. Toke received her medical degree from Gandhi Medical College, Osmania University, India and completed her residency in internal medicine at UC Davis. She went on to complete her nephrology fellowship at Stanford University, and, after a brief period on the faculty at UT Southwestern, joined UCSF as a faculty member in the Nephrology Division at ZSFG. 

 Anitha was widely viewed as a highly insightful diagnostician and skilled clinician. She had a unique ability to get to the heart of even the most complex clinical cases, and seemed to know exactly what do to in any clinical situation. Her skills and personal characteristics – including her candor and sense of humor – led her to become a key leader in nephrology at UCSF and throughout our region. 

 In addition to her clinical skills, Anitha was a superb administrator. She served as Director of Nephrology Outpatient Services at ZSFG. In this role, she oversaw two outpatient clinics, including the UCSF/SFGH Dialysis Center, which provides hemodialysis and peritoneal dialysis services to more than 120 patients within the ZSFG/SFDPH system. She improved treatment systems and, through her expeditious and thoughtful handling of the Covid-19 pandemic, avoided any serious outbreak within this population of highly vulnerable dialysis patients. 

While all of these represent tremendous contributions, her service as a teacher and role model for diverse groups of nephrology fellows, residents, and medical students will be her greatest professional legacy. She entered the field of nephrology when women were a small minority. She inspired all of the trainees she came in contact with, but particularly female doctors, who were inspired by her strength as a diagnostician, clinician, and leader.

While she was exceptional in her career, she never lost sight of the central importance of her family. She is survived by her husband Aditya Mukherjee and two children, Arav and Aarya. 

We thank Anitha Toke and send our heartfelt condolences to her family, as well as the many colleagues, trainees, and patients whose lives she touched. A memory board with comments/eulogies for Anitha can be found on the website of Skylawn Funeral Home and Memorial Park, where her funeral service was held last week.

Sincerely,

David Pearce MD
Chief, UCSF Division of Nephrology at ZSFG
Professor of Medicine

Neil R. Powe, MD, MPH, MBA
Chief of Medicine, Zuckerberg San Francisco General Hospital
Vice-Chair of Medicine, University of California San Francisco

Robert M. Wachter, MD
Chair, Department of Medicine